Global Next Generation Cancer Diagnostics Market to Reach $57.8 Billion by 2030
The global market for Next Generation Cancer Diagnostics estimated at US$14.9 Billion in the year 2023, is expected to reach US$57.8 Billion by 2030, growing at a CAGR of 21.4% over the analysis period 2023-2030. qPCR & Multiplexing Technology, one of the segments analyzed in the report, is expected to record a 22.4% CAGR and reach US$25.5 Billion by the end of the analysis period. Growth in the Next Generation Sequencing Technology segment is estimated at 17.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $4.7 Billion, While China is Forecast to Grow at 20.7% CAGR
The Next Generation Cancer Diagnostics market in the U.S. is estimated at US$4.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.9 Billion by the year 2030 trailing a CAGR of 20.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 19.1% and 17.8% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook